Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale Chief Financial Officer sold 1,697 shares at $6.03 ($10,233)
  2. 4 Open-market sale President, R&D sold 3,451 shares at $6.03 ($20,810)
  3. 4 Open-market sale Chief Legal Officer sold 1,632 shares at $6.03 ($9,841)
  4. 4 Grant or award President and CEO acquired 1,662 shares (grant or award)
  5. 4 Open-market sale President, R&D sold 648 shares at $8.38 ($5,430)
  6. 4 Open-market sale See remarks sold 244 shares at $8.38 ($2,045)
  7. 4 Open-market sale Chief Financial Officer sold 294 shares at $8.38 ($2,464)
  8. 4 Open-market sale Chief Legal Officer sold 294 shares at $8.38 ($2,464)
  9. 4 Open-market sale See remarks sold 1,352 shares at $11.80 ($15,954)
  10. 4 Open-market sale Chief Financial Officer sold 1,693 shares at $11.80 ($19,977)
  11. 4 Open-market sale President, R&D sold 2,683 shares at $11.80 ($31,659)
  12. 4 Open-market sale Chief Legal Officer sold 1,628 shares at $11.80 ($19,210)
  13. 4 Open-market sale See remarks sold 244 shares at $12.12 ($2,957)
  14. 4 Open-market sale Chief Financial Officer sold 294 shares at $12.12 ($3,563)
  15. 4 Open-market sale President, R&D sold 647 shares at $12.12 ($7,842)
  16. 4 Open-market sale Chief Legal Officer sold 294 shares at $12.12 ($3,563)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 16 · 320 filings